Outcomes with digoxin in atrial fibrillation: More data, no answers

Journal of the American College of Cardiology

Volumn 64, Issue 7, 2014, Pages 669-671

  Reynolds, Matthew R ^a,b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

atrial fibrillation; digoxin; mortality; safety

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN;

DISEASE SEVERITY; DRUG BLOOD LEVEL; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MORTALITY; NOTE; PATIENT SELECTION; POST HOC ANALYSIS; PRIORITY JOURNAL; PROPENSITY SCORE; UNSPECIFIED SIDE EFFECT;

ATRIAL FIBRILLATION; DIGOXIN; MORTALITY; SAFETY;

ATRIAL FIBRILLATION; DIGOXIN; FEMALE; HUMANS; MALE; OUTPATIENTS; RISK ASSESSMENT;

EID: 84905962699     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.04.070     Document Type: Editorial

References (13)

1. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
2. P. Hallberg, J. Lindback, B. Lindahl, U. Stenestrand, and H. Melhus Digoxin and mortality in atrial fibrillation: a prospective cohort study Eur J Clin Pharmacol 63 2007 959 971 (Pubitemid 47387912)
3. L. Friberg, N. Hammar, and M. Rosenqvist Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF) Heart 96 2010 275 280
4. M. Gheorghiade, G.C. Fonarow, and D.J. van Veldhuisen et al. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial Eur Heart J 34 2013 1489 1497
5. M.G. Whitbeck, R.J. Charnigo, and P. Khairy et al. Increased mortality among patients taking digoxin - analysis from the AFFIRM study Eur Heart J 34 2013 1481 1488
6. M.P. Turakhia, P. Santangeli, and W.C. Winkelmayer et al. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study J Am Coll Cardiol 64 2014 660 668
7. S.S. Rathore, Y. Wang, and H.M. Krumholz Sex-based differences in the effect of digoxin for the treatment of heart failure N Engl J Med 347 2002 1403 1411 (Pubitemid 35239712)
8. L. Friberg Safety of dronedarone in routine clinical care J Am Coll Cardiol 63 2014 2376 2384
9. L. Kober, C. Torp-Pedersen, and J.J. McMurray et al. Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687 (Pubitemid 351860860)
10. R. Farshi, D. Kistner, and J.S. Sarma et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens J Am Coll Cardiol 33 1999 304 310 (Pubitemid 29234189)
11. S.S. Rathore, J.P. Curtis, and Y. Wang et al. Association of serum digoxin concentration and outcomes in patients with heart failure JAMA 289 2003 871 878 (Pubitemid 37430346)
12. D.S. Budnitz, M.C. Lovegrove, N. Shehab, and C.L. Richards Emergency hospitalizations for adverse drug events in older Americans N Engl J Med 365 2011 2002 2012
13. C.T. January, L.S. Wann, and J.S. Alpert et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 2014 Mar 28 [E-pub ahead of print]